Valsacor film-coated tablets 80 mg 84 pcs.

Active ingredient: 1 film-coated tablet contains 40 mg or 80 mg, 160 mg, or 320 mg of valsartan;

Excipients: lactose, microcrystalline cellulose, povidone, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide (E 171), macrogol 4000, iron oxide yellow (E 172) – available on film-coated tablets of 40 mg, 160 mg and 320 mg, iron oxide red (E 172) – available on film-coated tablets of 80 mg, 160 mg and 320 mg.

Hypersensitivity to the active substance or to any of the components of the drug, severe liver dysfunction, biliary cirrhosis and cholestasis, pregnant women or women planning to become pregnant; concomitant use of angiotensin receptor antagonists, including valsartan, or ACE inhibitors with aliskiren in patients with diabetes mellitus or impaired renal function.

Valsacor should be taken regardless of meals, with water.

Pregnant women

Contraindicated.

Children

Valsartan should be used to treat arterial hypertension in children aged 6 years and older.

Drivers

As with other antihypertensive agents, caution should be exercised when driving or operating machinery due to possible dizziness or weakness.

Symptoms: Overdose with valsartan may result in severe hypotension, which may lead to depression of consciousness, vascular collapse and/or shock.

Treatment. Therapeutic measures depend on the time of administration and the type and severity of symptoms. The most important thing is to stabilize the circulatory status. In case of hypotension, the patient should be placed in the supine position and blood volume should be corrected.

It is unlikely that the drug can be removed by hemodialysis.

In patients with arterial hypertension, the overall incidence of adverse reactions is consistent with the pharmacology of valsartan. The incidence of adverse reactions was not related to dose or duration of treatment and was independent of gender, age or race.

When taking angiotensin II antagonists concomitantly with NSAIDs, a weakening of the antihypertensive effect is possible. Moreover, concomitant administration of angiotensin II antagonists and non-steroidal anti-inflammatory drugs may lead to a deterioration in renal function and serum potassium levels. Therefore, it is recommended to monitor renal function at the beginning of treatment, as well as to ensure adequate fluid intake.

Store at a temperature not exceeding 30 °C in the original packaging to protect from moisture.

Keep out of reach of children.

Shelf life – 5 years.